Hedge Funds Are Selling Threshold Pharmaceuticals, Inc. (THLD)
At the moment, there are tons of methods market participants can use to watch Mr. Market. A pair of the most useful are hedge fund and insider trading sentiment.
Oncolytics Biotech Inc (ONCY)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Is Coronado Biosciences Inc (CNDO) Going to Burn These Hedge Funds?
If you'd ask most market participants, hedge funds are viewed as worthless, old financial vehicles of years past.
Should You Avoid GTx, Inc. (GTXI)?
Is GTx, Inc. (NASDAQ:GTXI) a superb investment right now? Investors who are in the know are taking a pessimistic view.
Oncolytics Biotech, Inc. (USA) (ONCY): This High-Risk, High-Reward Biotech Is Worth a Look
Let me preface this by saying that investing in the biotech sector can sometimes be nothing more than speculating.
This Metric Says You Are Smart to Buy Curis, Inc. (CRIS)
Curis, Inc. (NASDAQ:CRIS) was in 10 hedge funds' portfolio at the end of March. CRIS investors should be aware of an increase in hedge fund interest in recent months.
Oncolytics Biotech, Inc. (USA) (ONCY): This Promising Biotech Can Triple
Cancer is one of the deadliest challenges that humans face today. Different forms of cancer have taken millions of lives all around the world.
Should You Buy Progenics Pharmaceuticals, Inc. (PGNX)?
In the eyes of most market participants, hedge funds are viewed as slow, outdated investment tools of the past.
Galena Biopharma Inc (GALE), Oncolytics Biotech, Inc. (USA) (ONCY): 2 Drugs With Acquisition Potential
Big pharmaceutical players, known as Big Pharma, depend on patents to fend of generic threats to their blockbuster drugs. So when a patent expires, cheaper generic products flood the market.
Amgen, Inc. (AMGN), Bristol Myers Squibb Co. (BMY): Can Financial Innovation Unlock a Cure for Cancer?
A few years ago, Andrew W. Lo from the MIT Sloan School of Management gave a lengthy talk at a meet-and-greet for prospective students of the Master of Finance program.
2 Biopharmaceuticals With Huge Upside Potential: Galena Biopharma Inc (GALE), Oncolytics Biotech, Inc. (USA) (ONCY)
The Biopharmaceutical industry has been one of the most profitable industries last year. A number of companies have appreciated to sky high valuations and returned investors a lot of money.
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
